Pres Clinton Sends Congress FY97 Budget

12 February 1996

To meet a legal requirement that the US President provides Congress with a spending plan for the next fiscal year by the first Monday in February, President Clinton has sent Congress the bare-bones outline of a $1.64 trillion budget for 1997. Details of the plan, which would balance the budget over the next seven years, are due the week of March 18.

With the deadlock over this year's budget still ongoing, no Congressional hearings on the new budget plan, which uses the Congressional Budget Office's conservative economic estimates, are scheduled.

One of the few initiatives mentioned in the program proposes subsidizing health insurance premiums for up to six months for people who lose their jobs. Some 3.8 million Americans would be covered annually, it was estimated, but no projected costs were given.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight